Seock-Ah Im, Carlos Rojas, Iván Victoria, Jin-Hee Ahn, John J. Park, Felipe Reyes, Giuseppe Curigliano, Mackenzie Edmondson, Nicole Myer, Adham Sean Bear, Mei Chen, Anna Spreafico. "Phase 1 study of the anti–immunoglobulin-like transcript 3 (ILT3) monoclonal antibody (mAb) MK-0482 + pembrolizumab (pembro) + paclitaxel for previously untreated advanced triple negative breast cancer (TNBC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e13135